Idamycin Pfs Solution
Product Images NDC 0013-2576

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Idamycin Pfs (NDC 0013-2576). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Idamycin 01)

Chemical structure of idarubicin hydrochloride, showing the molecular arrangement including hydroxyl groups, ketone groups, and an amine-containing sugar moiety bonded to the anthracycline core.*

FDA Label Image

Logo (Idamycin 02)

FDA Label Image

Principal Display Panel (5 mg/5 mL Vial Label)

Idamycin PFS 5 mg/5 mL solution label for intravenous use, containing idarubicin hydrochloride at 1 mg/mL strength. The label indicates it is a 5 mL single-dose vial of sterile, isotonic solution for IV use only, supplied by Pfizer Laboratories Division of Pfizer Inc. Storage instructions specify refrigeration at 2° to 8°C, protection from light, and cautions about severe cellulitis and tissue necrosis if the drug extravasates. The product is made in Australia.*

FDA Label Image

Principal Display Panel (5 mg/5 mL Vial Carton)

Packaging label for Idamycin PFS 5 mg/5 mL (1 mg/mL) idarubicin hydrochloride injection, a sterile isotonic solution for intravenous use. The label indicates a 5 mL single-dose CYTOSAFE vial, distributed by Pfizer Laboratories Div Pfizer Inc. Storage instructions specify refrigeration at 2° to 8°C and protection from light.*

FDA Label Image

Principal Display Panel (10 mg/10 mL Vial Label)

Label for Idamycin PFS 10 mg/10 mL (1 mg/mL) intravenous injection solution containing idarubicin hydrochloride. The sterile, isotonic solution is for IV use only and is supplied in a 10 mL single-dose vial. The label includes storage instructions, usage warnings, and details that it is made in Australia by Pfizer Laboratories Div Pfizer Inc.*

FDA Label Image

Principal Display Panel (10 mg/10 mL Vial Carton)

Packaging label for Idamycin PFS 10 mg/10 mL injectable solution, containing idarubicin hydrochloride at 1 mg/mL. The label specifies it is a 10 mL single-dose Cytosafe vial for intravenous use only, distributed by Pfizer Laboratories Div Pfizer Inc. Storage conditions require refrigeration between 2° to 8°C and protection from light. The label also includes warnings related to administration risks and formulation details.*

FDA Label Image

Principal Display Panel (20 mg/20 mL Vial Label)

Label for Idamycin PFS idarubicin hydrochloride injection, 20 mg/20 mL (1 mg/mL) solution for intravenous use. This single-dose vial contains sterile isotonic solution. The label includes storage instructions (2° to 8°C), cautions, usage directions, and is marked as Rx only. Distributed by Pfizer Laboratories Div Pfizer Inc.*

FDA Label Image

Principal Display Panel (20 mg/20 mL Vial Carton)

Packaging label for Idamycin PFS 20 mg/20 mL (1 mg/mL) injection, an intravenous solution of idarubicin hydrochloride. The label includes storage instructions, warnings, and dosage notes. Manufactured by Pfizer Laboratories, the label also shows barcode and lot/expiration information with a purple and white color scheme.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.